Home >> Research Area >>Natural Products>>Diterpenoids>> 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

CAS# 210108-91-1

5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

Catalog No. BCN1498----Order now to get a substantial discount!

Product Name & Size Price Stock
5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane:5mg Please Inquire In Stock
5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane:10mg Please Inquire In Stock
5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane:20mg Please Inquire In Stock
5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane:50mg Please Inquire In Stock

Quality Control of 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

Number of papers citing our products

Chemical structure

5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

3D structure

Chemical Properties of 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

Cas No. 210108-91-1 SDF Download SDF
PubChem ID 10794828 Appearance Powder
Formula C37H48O13 M.Wt 700.8
Type of Compound Diterpenoids Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name [(1S,2S,3aR,4R,4aS,4bS,6R,8S,8aS,9aR,10R,10aR)-4,6,8,8a,10-pentaacetyloxy-3a-hydroxy-2,4a,6,9a-tetramethyl-2,3,4,4b,5,7,8,9,10,10a-decahydro-1H-cyclopenta[b]fluoren-1-yl] benzoate
SMILES CC1CC2(C(C1OC(=O)C3=CC=CC=C3)C(C4(CC5(C(C4(C2OC(=O)C)C)CC(CC5OC(=O)C)(C)OC(=O)C)OC(=O)C)C)OC(=O)C)O
Standard InChIKey IKVFCMXVZDVCLH-IEBUTITNSA-N
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

The herbs of Euphorbia peplus

Protocol of 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

Structure Identification
Chinese Journal of Natural Medicines, 2010, 8(2):81-83.

A New Jatrophane Diterpenoid from Euphorbia peplus.[Reference: WebLink]

To study the chemical constituents of Euphorbia peplus.
METHODS AND RESULTS:
Compounds 1–3 were isolated and purified by silica gel column chromatography, MCI and Sephadex LH-20. Their structures were mainly elucidated by spectroscopic analysis and physicochemical characteristics. Three compounds were identified as euphopeplin A (1), 2α, 5α, 7β, 8α, 9α, 14β-hexaacetoxy-3β-benzoyloxy-15-hydroxyjatropha-6 (17), 11E-diene (2) and 5α, 8α, 9β, 10β, 14α-pentaacetoxy-3β-benzoy-loxy-15-hydroxypepluane (5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane,3).
CONCLUSIONS:
A new jatrophane diterpenoid, euphopeplin A (1) was isolated from Euphorbia peplus.

5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.4269 mL 7.1347 mL 14.2694 mL 28.5388 mL 35.6735 mL
5 mM 0.2854 mL 1.4269 mL 2.8539 mL 5.7078 mL 7.1347 mL
10 mM 0.1427 mL 0.7135 mL 1.4269 mL 2.8539 mL 3.5674 mL
50 mM 0.0285 mL 0.1427 mL 0.2854 mL 0.5708 mL 0.7135 mL
100 mM 0.0143 mL 0.0713 mL 0.1427 mL 0.2854 mL 0.3567 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

Determination of the stereoisomers in aqueous medium and serum and validation studies of racemic aminoalkanol derivatives of 1,7-dimethyl-8,9-diphenyl-4-azatricyclo[5.2.1.0(2,6) ]dec-8-ene-3,5,10-trione, potential new anticancer drugs, by capillary electrophoresis.[Pubmed:27421088]

J Sep Sci. 2016 Aug;39(16):3246-53.

A new method for the determination of the stereoisomers, in aqueous medium and serum, of the racemic aminoalkanol derivatives I and II of 1,7-dimethyl-8,9-diphenyl-4-azatricyclo[5.2.1.0(2,6) ]dec-8-ene-3,5,10-trione, which were found in earlier studies to be potential anticancer drugs, was developed and validated. The optimized conditions included 25 mM phosphate buffer adjusted to pH 2.5, containing gamma-cyclodextrin at a concentration of 5% m/v, as background electrolyte, an applied voltage of +10 kV, and a temperature of 25 degrees C. Separations were carried out using a fused-silica capillary. The developed method of determining the enantiomers of compounds I(S), I(R) and II(S), II(R) was characterized by the following parameters: a detection time within 10.8 min, a detection limit in the range of 141.2-141.7 ng/mL using the UV absorption detection at 200 nm. Good linearity (R(2) = 0.9989-0.9998) was achieved within the range of concentrations studied. A very good extraction yield of 95.4-99.7% was achieved, and recoveries were carried out from both aqueous solutions and matrix serum. The repeatability of the method for peak areas with an accuracy of the determined concentrations of the analytes in the range of 1.43-1.89%, and limits of quantitation in the range of 432.4-436.3 ng/mL were achieved.

Crystal structure of (acetato-kappaO)(ethanol-kappaO)[(9S,17S,21S,29S)-9,17,21,29-tetra-hydroxy-18,30- dioxa-octa-cyclo-[18.10.0.0(2,7).0(8,19).0(9,17).0(11,16).0(21,29).0(23,28)]triac onta-1,3,5,7,11(16),12,14,19,23(28),24,26-undeca-ene-10,22-dione-kappa(3) O (18),O (21),O (22)]caesium ethanol monosolvate.[Pubmed:27555923]

Acta Crystallogr E Crystallogr Commun. 2016 Jun 3;72(Pt 7):884-7.

The title compound, [Cs(CH3COO)(C28H16O8)(C2H5OH)].C2H5OH, is the product of the complexation between one vasarene analogue [1], bis ninhydrin naphthalene-1,3-diol and CsF, where the F(-) ion has reacted with residual acetic acid (AcOH), to form a [1].CsOAc complex. The inter-molecular inter-actions with the multiple oxygen-containing functional groups of the ligand, as well as O-Hcdots, three dots, centeredO hydrogen bonds involving the ethanol solvent mol-ecules, stabilize the complex, forming a chain along [100]. Additional parallel-displaced pi-pi stacking, with an inter-planar distance of 3.669 (1) A, connect several unit cells in a three-dimensional supra-molecular structure, though, the larger size of AcO(-) (1.60 A) compared to F(-) (1.33 A) prevents the tight packing that was once achieved with other vasarene complexes of CsF.

Spectral investigation of the effect of anion on the stability of non covalent assemblies of 2,3,5,6,8,9,11,12-octahydro-1,4,7,10,13-benzopentaoxacyclopentadecine (benzo-15-crown-5) with sodium halides.[Pubmed:27591702]

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Jan 15;171:507-514.

A series of complexes of 2,3,5,6,8,9,11,12-octahydro-1,4,7,10,13-benzopentaoxacyclopentadecine (benzo-15-crown-5) with sodium halides was synthesized in acetonitrile. The effect of anion on the stability and spectral properties of complexes of benzo-15-crown-5 with sodium halides was investigated. The synthesis of complexes of sodium fluoride and sodium chloride are reported for the first time. Chloroform was used as solvent to study the assembly in solution state by (1)H and (13)C NMR techniques. Single crystal diffraction studies on the easily crystallizable bromide complex confirmed 1:1 stoichiometry of the complex. IR and Raman studies provided valuable evidence for a water molecule shared between the crown encapsulated cation and the counter ion to give a solvent shared ion pair (SSIP). The fluorescence spectra of the complexes were obtained in chloroform by excitation at 270nm to study the effect of complexation on the fluorescent properties of benzo-15-crown-5.

Hybrid gels by conjugation of hyaluronic acid with poly(itaconic anhydride-co-3,9-divinyl-2,4,8,10-tetraoxaspiro (5.5)undecane) copolymers.[Pubmed:28153463]

Int J Biol Macromol. 2017 May;98:407-418.

The approach of covalent conjugation for coupling synthetic polymers with biomolecules represents an appealing strategy to produce new compounds with distinctive properties for biomedical applications. In the present study we generated hybrid gels with tunable characteristics by using hyaluronic acid (HA) and four variants of poly(itaconic anhydride-co-3,9-divinyl-2,4,8,10-tetraoxaspiro[5.5] undecane) (PITAU) copolymers, differing through the molar ratios between comonomers. The new bioconjugate compounds were realized by using a ''grafting to'' strategy, for further ensuring new ways for coupling of various bioactive compounds, taking into account that the grafted copolymers are dual sensitive to pH and temperature. The procedure of chemical crosslinking, by opening the anhydride cycle of the copolymer with the hydroxyl groups of hyaluronic acid, was used to prepare the bioconjugates. The chemical conjugation between HA and PITAU copolymers, as well as the structure of the new compounds, was confirmed by FTIR and NMR techniques. The physical properties of the new gels as thermal stability, swelling capacity, and rheological properties were investigated. The bioconjugate networks were also investigated as drug delivery carriers by using indomethacin as a model drug. In vitro and in vivo tests attested the homogeneity of the bioactive compounds as well as a good biochemical response, showing good biocompatibility for the new structures.

Keywords:

5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane,210108-91-1,Natural Products, buy 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane , 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane supplier , purchase 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane , 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane cost , 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane manufacturer , order 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane , high purity 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: